CLMTCalumet, Inc.
$56.42+205% 1Y
$56.42
$17.6852 weeks$59.04
CLMT as reported
Calumet, Inc. reported $4.59B of revenue over the trailing twelve months, +13% on the year before. 10 reported series are charted on this page, each one as filed.
$4.59B
Revenue, trailing twelve months · to Q2 2026 · +13% against the twelve months before
- Net income
- −$137M
Net income · −70% year on year · trailing twelve months to Q2 2026
- Free cash flow
- $58M
Free cash flow · −145% year on year · trailing twelve months to Q2 2026
- Operating margin
- 1.1%
Operating margin · trailing twelve months to Q2 2026
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $4.59B | +13% | Q2 2026 |
| Net income | −$137M | −70% | Q2 2026 |
| EPS | −$1.55 | −70% | Q2 2026 |
| Gross margin | 6.8% | n/a | Q2 2026 |
| Operating margin | 1.1% | n/a | Q2 2026 |
| Net margin | −3.0% | n/a | Q2 2026 |
| ROE | 10% | n/a | Q2 2026 |
| ROA | −3.6% | n/a | Q2 2026 |
| ROIC | 4.8% | n/a | Q2 2026 |
| Free cash flow | $58M | −145% | Q2 2026 |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
Calumet, Inc. (CLMT) · Revenue and profitRevenue and profitCalumet, Inc. (CLMT)
RevenueNet incomeTrailing twelve months
Powered byryufin.com
Specialty Chemicals
Ranks #31 of 33 by RyuScore